Home Contact us Site Map
job opportunities
 
 
Position Requirement Location
Officer - Production 1 Tarapur
Officer Quality Assurance 1 Tarapur
Officer Safety 2 Tarapur
Officer Quality Control 2 Tarapur
Manager /Sr. Manager - Accounts, Finance & Costing 1 Andheri
Manager Sales 1 Andheri
Accounts Assistant 1 Andheri
Senior Executive Purchase 1 Andheri
 
Interested candidates can apply to any of these positions to hrd@calyxindia.com along with updated CV.

HR Contact Person: Ms.Shruti Kulkarni / Ms.Deepali Dalvi / Ms.Neelam Parekh
R&D Centre: A-37/38.MIDC,Phase-I,Golavli, Kalyan-Shil Road, Dombivli (E),Thane -421203.
Tel: +91-251-6698300 Fax: +91-22-66466401. (Ext.554 / 620)
Regd Office: Unit No.110, Marwah’s Complex, Krishanlal Marwah Marg, Off. Saki Vihar Road,Andheri (East), Mumbai – 400072
Tel: +91-22-28571191 Fax: +91-22-66466416
Tarapur Plant: N-102/91, MIDC ,Tarapur , Boisar , Dist.Thane - 401506
Tel: +91-2525-274858 Fax: +91-22-66466426 (Ext.201)


"Calyx Chemicals and Pharmaceuticals Limited (the “Company”) is proposing to make, subject to receipt of requisite approvals, market conditions and other considerations, an Initial Public Offering of its equity shares (the “IPO") and has filed the Draft Red Herring Prospectus (the “DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of SEBI at www.sebi.gov.in, the website of the BRLMs, i.e. PL Capital Markets Private Limited at www.plindia.com and YES Bank Limited at www.yesbank.in and is also available on the website of the Company at www.calyx-pharma.com. Potential investors should note that investment in equity shares involves a degree of risk. For details, please refer to the DRHP, including the section titled “Risk Factors” of the DRHP. This publicity material does not constitute an offer of securities in any jurisdiction, including the United States of America (“USA”). Securities may not be offered or sold in the USA without registration under the U.S. Securities Act of 1933 as amended, or an exemption therefrom. The Company has not and does not intend to offer any securities to the public in the USA."
 
 
copyright © Calyx Chemicals & Pharmaceuticals Ltd.